#AstraZeneca's rare disease unit #Alexion has claimed a positive opinion from the #EMA's human medicines committee for #generalisedmyastheniagravis (gMG) therapy #Klygefa.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#AstraZeneca's rare disease unit #Alexion has claimed a positive opinion from the #EMA's human medicines committee for #generalisedmyastheniagravis (gMG) therapy #Klygefa.
@newsen.bsky.socialKlygefa®: A New Hope for Adults with Generalized Myasthenia Gravis in Japan #Japan #Myasthenia_Gravis #Minato-ku,_Tokyo #Klygefa #Alexion_Pharma